Michael Choi, MD
University of California, San Diego · UC San Diego Moores Cancer Center · Moores Cancer Center, UCSD
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Michael Choi, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 04:01 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT03422393 · Venetoclax With High-dose Ibrutinib for CLL Progressing on Single Agent IbrutinibMichael Choi · active not recruiting · Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma · principal investigator
- Ph1/Ph2NCT03088878 · A Study of Cirmtuzumab and Ibrutinib in Patients With B-Cell Lymphoid MalignanciesOncternal Therapeutics, Inc · completed · B-cell Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma · principal investigator
- Ph1NCT02784834 · Dimethylfumarate (DMF) in Relapsed/Refractory CLL/SLLMichael Choi · terminated · Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma · principal investigator
- Ph1NCT02611908 · Obinutuzumab With High-dose Ibrutinib for the Treatment of Patients With Chronic Lymphocytic Leukemia With Progressive Disease on Single Agent Ibrutinib.Michael Choi · withdrawn · Chronic Lymphocytic Leukemia · principal investigator
- Ph2NCT02371577 · Evaluation of the Immune Restoration Potential Of LenalidomideUniversity of California, San Diego · withdrawn · Chronic Lymphocytic Leukemia (CLL) · principal investigator
- Ph2NCT02371590 · Lenalidomide and Obinutuzumab for Previously Untreated CLLUniversity of California, San Diego · withdrawn · Chronic Lymphocytic Leukemia · principal investigator
- Ph2NCT02046928 · Safety, Tolerability and Efficacy of A6 in Patients With Chronic Lymphocytic Leukemia (CLL)Ångstrom Pharmaceuticals · terminated · Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, CLL · principal investigator
- Ph1NCT01955668 · AZD6738 First Time in Patient Multiple Ascending Dose StudyAstraZeneca · completed · 11q-deleted Relapsed/Refractory Chronic Lymphocytic Leukaemia (CLL),, Prolymphocytic Leukaemia (PLL), B Cell Lymphomas · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 04:01 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.